-
1دورية أكاديمية
المؤلفون: Yun Kyung Cho1 chjung0204@gmail.com, Ye-Jee Kim2, Chang Hee Jung3,4
المصدر: Journal of Obesity & Metabolic Syndrome. Dec2021, Vol. 30 Issue 4, p336-344. 9p.
مصطلحات موضوعية: *SODIUM-glucose cotransporter 2 inhibitors, *WEIGHT loss, *SODIUM-glucose cotransporters, *HDL cholesterol, *LEPTIN, *LDL cholesterol, *OBESITY
-
2دورية أكاديمية
المؤلفون: Ju-Young Hong1, Keun-Young Park1, Jong-Dai Kim1, Won-Min Hwang2, Dong-Mee Lim1,3 mdldm@hanmail.net
المصدر: Journal of Obesity & Metabolic Syndrome. Sep2020, Vol. 29 Issue 3, p215-221. 7p.
مصطلحات موضوعية: *TYPE 2 diabetes, *SODIUM-glucose cotransporter 2 inhibitors, *CARDIOVASCULAR diseases, *ENDOTHELIUM diseases, *PEOPLE with diabetes
-
3دورية أكاديمية
المؤلفون: Chan-Hee Jung, Ji-Oh Mok
المصدر: Journal of Obesity & Metabolic Syndrome, Vol 28, Iss 1, Pp 18-29 (2019)
مصطلحات موضوعية: Sodium-glucose cotransporter 2 inhibitor, Glucagon-like peptide-1 receptor agonist, Non-alcoholic fatty liver disease, Type 2 diabetes mellitus, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2508-6235Test
-
4دورية أكاديمية
المؤلفون: Sook Jung Lee, Kook Hyung Lee, Hyun Geong Oh, Hye Ji Seo, Soo Jin Jeong, Chong Hwa Kim
المصدر: Journal of Obesity & Metabolic Syndrome; Dec2019, Vol. 28 Issue 4, p254-261, 8p
مصطلحات موضوعية: BRAIN natriuretic factor, TYPE 2 diabetes, CD26 antigen, CORONARY disease, CARDIOVASCULAR diseases, VENTRICULAR ejection fraction, SODIUM-glucose cotransporter 2 inhibitors
-
5
المؤلفون: Ji-Oh Mok, Chan-Hee Jung
المصدر: Journal of Obesity & Metabolic Syndrome
Journal of Obesity & Metabolic Syndrome, Vol 28, Iss 1, Pp 18-29 (2019)مصطلحات موضوعية: lcsh:RC648-665, business.industry, Endocrinology, Diabetes and Metabolism, Fatty liver, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, Review, Pharmacology, medicine.disease, Glucagon-like peptide-1, lcsh:Diseases of the endocrine glands. Clinical endocrinology, digestive system, digestive system diseases, Sodium-glucose cotransporter 2 inhibitor, Pharmacotherapy, Sodium/Glucose Cotransporter 2, Type 2 diabetes mellitus, Medicine, Glucagon-like peptide-1 receptor agonist, Steatohepatitis, Receptor, business, Glucagon-like peptide 1 receptor, Non-alcoholic fatty liver disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e80ad7c1b618bd1869451b20755637dTest
http://europepmc.org/articles/PMC6484938Test